RAG2 and colitis: NMN administration protected Rag2–/– mice from CCl4‐aggravated DSS colitis (Figure 3C‐F), but no discernible impact was observed in CCl4‐combined DSS colitis in Rag2–/–Il2rg–/– mice (Figure 3G‐J).